The Board has determined that the Veteran's essential thrombocytosis may be related to his service, but an adequate medical opinion is needed to establish this relationship. The appeal is being remanded for further development.
The deciding factor: An adequate medical opinion is required to determine if the Veteran's essential thrombocytosis is related to his in-service herbicide agent exposure or any other service-connected condition.
- Claimed conditions
- essential thrombocytosis
- How they argued it
- Not specified
- Exposure basis
- None
- Rating
- Not verified here — check the original decision
- Decision date
- May 24, 2021
- Citation
- 21031670
This is a plain-language summary generated by AI from a public Board of Veterans’ Appeals decision. It can contain errors — always verify against the original. Read the original VA decision (opens in a new tab) using citation 21031670.
What this means for you
A remand sends an issue back for more development, often a new examination or missing records. It does not award the benefit or decide the final outcome. The original decision explains the additional work ordered.
What you can do next
Use your own notice and decision stage. A remanded issue is not a final court-appealable denial. VA review guidance and CAVC filing instructions (U.S. federal; reviewed October 7, 2026).
Related decisions
Other Board decisions on a similar condition or argued the same way.
- Whole decision: Granted
The Board has determined that the evidence is in equipoise regarding whether the Veteran's essential thrombocytosis is related to service, specifically herbicide exposure. As such, the claim for service connection is granted.
- Whole decision: Remanded (sent back)
The Board remands the claim for essential thrombocytosis to obtain an addendum opinion addressing all toxic exposure risks, including herbicides.
- Whole decision: Denied
The Board denied the Veteran's claim for an initial compensable rating for essential thrombocytosis as there was no evidence of continuous or intermittent myelosuppressive therapy, chemotherapy, or interferon treatment.
- Whole decision: Dismissed
The Veteran withdrew his appeal of the denial of service connection for myeloproliferative disease with essential thrombocytosis.
Free starter guide for your own claim
Reading this because you were denied or under-rated? Get the plain-English next steps — your appeal options, the deadline that protects you, and how appeals like yours turn out. One email, no spam.
We will only use this to send the guide. No spam, unsubscribe any time. We never sell your information.
We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.
This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.